Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Why Docs Are Skittish About Prescribing Provenge
Pharmalot
Tue, 08/30/11 - 11:37 am
Tags:
Provenge, physicians, prostate cancer, Dendreon
Dendreon's Golden Age Is Still On Track
Seeking Alpha
Mon, 08/29/11 - 01:43 pm
Tags:
Dendreon, Provenge, prostate cancer
Dendreon: The Challenge Of Misinformation
Seeking Alpha
Mon, 08/29/11 - 11:00 am
Tags:
Dendreon, Provenge, prostate cancer
6 Healthcare Stocks Primed For A Rebound
Seeking Alpha
Fri, 08/26/11 - 09:16 am
Tags:
Apricus Biosciences, CytRx, Geron, Dendreon, SIGA technologies, ImmunoCellular
Payers expect Provenge sales to stay flat
Fierce Pharma
Thu, 08/25/11 - 11:49 am
Tags:
Dendreon, Provenge, prostate cancer
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Bloomberg
Mon, 08/22/11 - 06:13 pm
Tags:
Seattle Genetics, Dendreon, Provenge, Adcetris, lymphoma
How Undervalued Dendreon Is
Seeking Alpha
Fri, 08/19/11 - 11:16 am
Tags:
Dendreon, Provenge, prostate cancer
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers
Marketwatch
Fri, 08/19/11 - 09:20 am
Tags:
Dendreon, Provenge, Savient, Human Genome Sciences, Vertex Pharmaceuticals, InterMune, Seattle Genetics
Navigating Cancer Vaccines' High-Risk/High-Reward Field
Seeking Alpha
Wed, 08/17/11 - 12:09 pm
Tags:
cancer, vaccines, Dendreon, Provenge, ICT-107, ImmunoCellular, Amgen
Take a Chance on Dendreon Corp
Seeking Alpha
Tue, 08/16/11 - 10:05 am
Tags:
Dendreon, Provenge, prostate cancer
Dendreon and Provenge: Too High of a Risk for the Reward
Seeking Alpha
Mon, 08/15/11 - 06:30 pm
Tags:
prostate cancer, Dendreon, Provenge, JNJ
When to Buy Biotechnology Stocks?
Seeking Alpha
Mon, 08/15/11 - 10:30 am
Tags:
Alexion, Arena Pharmaceuticals, Dendreon, Human Genome Sciences, MannKind, Orexigen
5 Cheap Biotech Stocks That May Rebound Ahead of the Market
Seeking Alpha
Fri, 08/12/11 - 12:43 pm
Tags:
BioSante, Chelsea Therapeutics, Dendreon, Keryx, Opexa
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
Tags:
biotech, drug approvals, FDA, Eyelea, Regeneron, Dendreon, Provenge, NuPathe, Zelrix, Adcetris, Seattle Genetics, Soliris, Alexion, Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, EXPAREL, Pacira, Roche, Zelboraf, Iluvien, Alimera, Bio-T-Gel, Teva Pharmaceuticals, BioSante, Zevalin, Spectrum, ruxolitinib, Incyte, Novartis, Pfizer, crizotinib, Antares, Anturol, Bydureon, Amlyin, Eli Lilly, Alkermes, AZ-004, Alexza, Corlux, Corcept Therapeutics, Affymax, Takeda, peginesatide, Levadex, MAP Pharmaceuticals
Good Biotech Stocks for a Bear Market
TheStreet.com
Tue, 08/9/11 - 01:27 pm
Tags:
Elan, Targacept, Dendreon, Gilead Sciences, Sequenom, Vertex Pharmaceuticals, Amgen, Alexion, Biogen Idec, Celgene
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Mon, 08/8/11 - 09:18 am
Tags:
Dendreon, biotech, Provenge, prostate cancer
Still Want to Be the Next Dendreon?
Motley Fool
Sat, 08/6/11 - 01:01 pm
Tags:
Dendreon, Vertex Pharmaceuticals, Incivek, hepatitis B
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Seeking Alpha
Sat, 08/6/11 - 12:59 pm
Tags:
Dendreon, Provenge
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dendreon Corporation of Class Action Lawsuit and the October 4, 2011 Lead Plaintiff Deadline
Yahoo/MarketWire
Sat, 08/6/11 - 12:57 pm
Tags:
Dendreon, lawsuits
Do Dendreon's Problems Matter to Your Biotech Portfolio?
Seeking Alpha
Sat, 08/6/11 - 12:56 pm
Tags:
Dendreon, Provenge

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.